Three new commercial appointments for Symbiosis Three new commercial appointments for Symbiosis Symbiosis Pharmaceutical Services has expanded its commercial team with three new appointments as the specialist aseptic fill-finish CDMO targets further growth across... Lonza nominates Pearl Huang to board Lonza nominates Pearl Huang to board Lonza has nominated Pearl Huang as an independent member of its Board of Directors, bringing extensive pharmaceutical and biotechnology experience and expertise in drug... BioDuro appoints Greg Makara to lead discovery chemistry BioDuro appoints Greg Makara to lead discovery chemistry BioDuro has appointed Greg Makara, PhD, as Senior Vice President, Lead Discovery Chemistry, as the contract research, development and manufacturing organisation (CRDMO) looks... Alcami strengthens commercial operations with appointment of Will Isom Alcami strengthens commercial operations with appointment of Will Isom New appointment supports laboratory services sales and biologics growth Nuclera appoints Carl Raimond as Chief Executive Officer Nuclera appoints Carl Raimond as Chief Executive Officer Former Olink Proteomics president brings life-science tools leadership experience as Dr Michael Chen transitions to chief scientific and business officer Alcami strengthens commercial operations with appointment of Will Isom as Vice President of Laboratory Services Sales Alcami strengthens commercial operations with appointment of Will Isom as Vice President of Laboratory Services Sales Alcami, a leading contract development and manufacturing organisation (CDMO), today announced the appointment of biologics industry veteran Will Isom as Vice President of... Codis appoints Steven Facer as Chief Commercial Officer Codis appoints Steven Facer as Chief Commercial Officer Codis, a global contract development and manufacturing organisation (CDMO) specialising in spray drying, amorphous solid dispersions (ASDs), and advanced particle engineering,... Qinecsa selected as technology partner for Africa’s new continent-wide medicines safety platform Qinecsa selected as technology partner for Africa’s new continent-wide medicines safety platform Qinecsa will help deliver a continent-wide medicines safety platform connecting safety data across Africa Chiesi appoints David Khougazian as Group chief executive officer Chiesi appoints David Khougazian as Group chief executive officer David Khougazian to lead the next phase of innovation-driven growth CordenPharma appoints Dr Jean-Luc Herbeaux as Chief Executive Officer CordenPharma appoints Dr Jean-Luc Herbeaux as Chief Executive Officer Leadership transition marks the next phase of growth following 12 years of transformation under Dr Michael Quirmbach Gerresheimer names new Chairman of the Supervisory Board Gerresheimer names new Chairman of the Supervisory Board This year's AGM featured the election of four shareholder representatives to the Supervisory Board, including Sieger as Chairman Scenic Biotech appoints renowned neurology drug development leader Dr. Judith Walker as Chief Medical Officer Scenic Biotech appoints renowned neurology drug development leader Dr. Judith Walker as Chief Medical Officer Dr. Walker joins to lead Scenic's transition into clinical development and shape its clinical strategy Hovione appoints Stefan Doboczky as Chief Executive Officer Hovione appoints Stefan Doboczky as Chief Executive Officer Chairman of the board of directors Stefan Doboczky to take over operational leadership of the family-owned pharmaceutical technology and services group on April 1, 2027 Yusen Logistics appoints Gilbert den Bekker as chief commercial officer for Europe Yusen Logistics appoints Gilbert den Bekker as chief commercial officer for Europe Experienced commercial leader joins Yusen Logistics to support sustainable growth and strengthen commercial collaboration across Europe Jos Vergeest appointed at Symbiosis, bringing three decades of pharmaceutical experience Jos Vergeest appointed at Symbiosis, bringing three decades of pharmaceutical experience Specialist pharmaceutical experience strengthens Symbiosis’ international growth ambitions Virginie Cavalli appointed Chief Executive Officer of Seppic Virginie Cavalli appointed Chief Executive Officer of Seppic Seppic announces the appointment of Virginie Cavalli as Chief Executive Officer, effective September 1, 2026